⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AGIO News
Agios Pharmaceuticals, Inc.
Agios Outlines 2026 Strategic Priorities and Key Milestones to Accelerate Rare Disease Portfolio Growth
globenewswire.com
AGIO
AGIO ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Agios Pharmaceuticals, Inc. Shareholders Who Lost Money
accessnewswire.com
AGIO
Agios Pharmaceuticals, Inc. Being Investigated on Behalf of Agios Pharmaceuticals, Inc. Investors. Contact Levi & Korsinsky For Details
accessnewswire.com
AGIO
Agios to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
globenewswire.com
AGIO
U.S. FDA Approves Agios’ AQVESME™ (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia
globenewswire.com
AGIO
Agios Pharmaceuticals, Inc. Being Investigated on Behalf of Agios Pharmaceuticals, Inc. Investors. Contact Levi & Korsinsky For Details
accessnewswire.com
AGIO
AGIO ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Agios Pharmaceuticals, Inc. investment
accessnewswire.com
AGIO
Lost Money on Agios Pharmaceuticals, Inc.(AGIO)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky
accessnewswire.com
AGIO
Agios Pharmaceuticals, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - AGIO
accessnewswire.com
AGIO
Agios Pharmaceuticals, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - AGIO
accessnewswire.com
AGIO